Skip to content ↓

In the Media

Displaying 15 news clips on page 42

Curiosity Stream

Four faculty members from across MIT - Professors Song Han, Simon Johnson, Yoon Kim and Rosalind Picard - speak with Curiosity Stream about the opportunities and risks posed by the rapid advancements in the field of AI. “We do want to think about which human capabilities we treasure,” says Picard. She adds that during the Covid-19 pandemic, “we saw a lot of loss of people's ability to communicate with one another face-to-face when their world moved online. I think we need to be thoughtful and intentional about what we're building with the technology and whether it's diminishing who we are or enhancing it.”

Forbes

Forbes contributor Lucio Ribeiro spotlights Andrew Ng MS '98 and Jaime Teevan SM '01, PhD '07 as two of eight “AI superheroes whose work is transforming technology and challenges our understanding of what’s possible.” Ng is the CEO is Landing AI, and “his efforts in educating the masses about AI through platforms like Coursera, which he co-founded, have democratized AI knowledge, bridging the gap between academia and industry,” writes Ribeiro. Teevan’s “work is focused on making AI more accessible and useful to people in their everyday lives.”

Financial Times

Financial Times reporter Andrew Hill highlights “The Geek Way,” a new book by Principal Research Scientist Andrew McAfee that explores the success behind “geek” culture in companies. Hill notes that McAfee has, “pinpointed some important norms sustaining the world’s most admired, and fastest growing, organizations.”

Fortune

Prof. Rudolf Jaenisch speaks with Fortune reporter Carolyn Barber about the immune system’s response to Covid-19. “The immune system is really stimulated–it’s in hyperdrive,” says Jaenisch. 

Nature

MIT researchers have “used an algorithm to sort through millions of genomes to find new, rare types of CRISPR systems that could eventually be adapted into genome-editing tools,” writes Sara Reardon for Nature. “We are just amazed at the diversity of CRISPR systems,” says Prof. Feng Zhang. “Doing this analysis kind of allows us to kill two birds with one stone: both study biology and also potentially find useful things.”

Time Magazine

Prof. Yet-Ming Chiang has been named to the TIME 100 Climate list, which highlights the world’s most influential climate leaders in business. “When it comes to cleantech, if it won’t scale, it doesn’t matter,” Chiang says. “This is a team sport—companies large and small, and governments state and federal, need to work together to get these new technologies out there where they can have impact.” 

The Wall Street Journal

Prof. Jacopo Buongiorno speaks with Danny Lewis, host of The Wall Street Journal’s “Future of Everything” podcast, about the future of nuclear power plants. “As countries, regions, businesses contemplate their future plans for reducing carbon emissions, nuclear is one technology that they have got to consider,” says Buongiorno. “It's an incredibly dense energy source, so you don't need a big supply chain that continuously feeds the power plant with fuel, the same way that you would with coal, for example. Also, the machine itself, the reactor is very, very compact.”

The Hill

Grace Colón PhD '95, a board member of the MIT Corporation, writes for The Hill about how to transform cities into biotech innovations hubs. “The best path to biotech success will be different for each city,” writes Colón. “But by building on institutional strengths, investing in workers, and knocking down barriers to success, there’s no reason more of them can’t get there.”

Bloomberg

Principal Research Scientist Andrew McAfee speaks with Bloomberg hosts Carol Massar and Tim Steinbeck about his new book “The Geek Way” and the future of artificial intelligence. “I personally am not worried about the existential, the alignment risks of AI,” says McAfee. “All very powerful tools bring risks and harm with them, and they demand vigilance. We have got to be careful about it. I don’t think AI is any big exception to that trend or requires us to do radically different things, we just have to be vigilant and stop the bad uses.”

MSNBC

Prof. Adam Berinsky speaks with MSNBC’s Morning Joe about the impact of misinformation on democracy and the upcoming 2024 election. “The larger issue is that there is this climate of distrust,” says Berinsky. 

WBUR

MIT Sloan Lecturer Shira Springer speaks with WBUR host Robin Young about the future of women’s sports coverage. “It does require extra effort on the part of the fan to find coverage on the streaming platforms,” says Springer. “And that is a problem because what you are trying to do in women’s sports is convert casual fans to avid fans and maybe bring in people who simply were not aware of what women’s sports offers, and to do what you need to be easily discoverable.”

HealthDay News

Researchers from MIT and elsewhere have developed a swallowable “technopill” that can monitor vital signs from inside the body, reports Dennis Thompson for HealthDay. “The ability to facilitate diagnosis and monitor many conditions without having to go into a hospital can provide patients with easier access to healthcare and support treatment,” says Prof. Giovanni Traverso.

Forbes

Forbes reporter Nancy Wang spotlights Tara Bishop '97 and Eileen Tanghal '97, co-founders of Black Opal Ventures, a venture capital firm focused on health tech. “Tara and Eileen’s story at Black Opal Ventures is a testament to how diversity and innovation can disrupt traditional landscapes,” writes Wang. “Their pioneering strategies and investments herald a new era for healthcare venture capitalism, where diversity and technology converge to create a more inclusive and impactful future.”

The Independent

Principal Research Scientist Emre Gençer speaks with The Independent reporter Louise Boyle about natural hydrogen and its potential as a future renewable energy source. “There is a ‘mismatch’ where natural hydrogen is being discovered and where it could be used, which would require massive investments in completely new infrastructure,” says Gençer. “I think it will be part of the solution but we need to take it with a grain of salt.”